European Medicines Agency’s clarification regarding re-testing exemption for imported advanced therapy medicinal products

On 21 August 2019, the European Medicines Agency (EMA) published questions and answers regarding imported advanced therapy medicinal products (ATMP). The document focuses on the possibility of batch controls exemption for ATMP imported into the European Union from a third country. It provides guidance concerning grant of the exemption, data to be submitted in order to justify such exemption and obligations of the qualified person for batch control.

Click here to read the full article.

Share Back to main blog
Loading data